Application and safety of tranexamic acid in total knee arthroplasty

doi:10.3969/j.issn.2095-4344.2016.09.016

Abstract

Abstract:

BACKGROUND: Studies suggested that blood loss was great during total knee arthroplasty, even blood transfusion was needed. Application of the tourniquet will destroy the coagulation system, and is not conducive to hemostasis after replacement. Recently, tranexamic acid has been extensively used to reduce blood loss during total knee arthroplasty, because of low price, simple administration pathway, and effective effects on hemostasis.
OBJECTIVE: To summarize the application and safety of tranexamic acid in total knee arthroplasty.
METHODS: The first author retrieved PubMed and Chinese Journal Full Text Database for articles from inception to October 2015. The key words were tranexamic acid, total knee arthroplasty, hemorrhage. More than 200 articles were retrieved, and finally 50 articles met the inclusion criteria.
RESULTS AND CONCLUSION: Tranexamic acid is a fibrinolytic inhibitor, can reversibly block the binding of plasminogen to fibrin, effectively inhibit fibrinolysis, and reduce hemorrhage after total knee arthroplasty. Nevertheless, there were significant differences in the use, dose and effect of tranexamic acid on hemostasis among different studies. Tranexamic acid was an effective drug for hemostasis during total knee arthroplasty. During total knee arthroplasty, tranexamic acid had been used to reduce dominant blood loss and hidden blood loss after arthroplasty, and could not increase the risk for venous thrombosis of lower limb. Currently, the timing of use, dosage, route of administration, and possible complications of tranexamic acid remain controversial.

中国组织工程研究杂志出版内容重点：人工关节；骨植入物；脊柱；骨折；内固定；数字化骨科；组织工程

Lin Ye, Zhang Guo-liang, Wang Yue-wen. Application and safety of tranexamic acid in total knee arthroplasty [J]. Chinese Journal of Tissue Engineering Research, 2016, 20(9): 1322-1328.

References

[1] Tan J,Chen H,Liu Q,et al. A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty. J Surg Res. 2013;2;880-887.

[2] Georgiadis AG,Muh SJ,Sliverton CD,et al. A prospective double-blind placebo controlled trial of topic tranexamic acid in total knee arthroplasty.J Arthroplasty. 2013;8:78-82.

[3] Lee SH, Cho KY,Khurana S,et al. Less blood loss under concomitant administration of topic tranexamic acid and indirect factor Xa inhibitor following total knee arthroplasty: a prospective randomized controlled trail. Knee Surg Sports Traumatol Arthrosc. 2013;11:2611-2617.

[4] Hynes MC,Calder P,Rosenfeld P,et al. The use of the tranexamic acid to reduce bloof loss during total hip arthroplasty: an observational study. Ann R Coll Srug Engl. 2005;2:99-101.

[5] MacGillivray RG,Tarabichi SB,Hawari MF,et al.Tranexamic acid to reduce bloof loss after bilateral total knee arthroplasty:a prospective,randomized double blind study. J Arthroplasty. 2011;1:1:24-28.

[6] Frisch NB, Wessell NM, Charters MA, et al. Predictor and complications of blood transfusion in total hip and knee arthroplasty. J Arthoplasty. 2014;29:189-192.

[7] 尹建石,刘欣伟,赵东风,等.术中关节腔内注射氨甲环酸对TKA失血量的影响[J].中国骨与关节损伤杂志, 2015, 2(30):205-206.

[8] Tai TW,Chang CW,Lai KA,et al.Effects of tourniquet use on blood loss and soft-tissue damage in total knee arthroplasty:a randomized controlled trail. J Bone Joint Surg Am. 2012;94(24):2209-2215.

[9] Petaja J,Myllynen P,Myllyla G,et al. Fibrinolysis after application of a pneumatic tourniquet. Acta Chir Scand. 1987;153(11-12):647-651.

[10] 王立强,张卫星,刘建刚,等.氨甲环酸对全膝关节置换术后出血量的影响[J].临床合理用药杂志,2015,8(7):59-60.

[11] McCormack PL.Tranexamic acid:a review of its use in the treatment of hyperfibrinolysis. Drugs. 2012;72(5): 471-479.

[12] 黄晓楠,张勇. 前瞻性随机对照研究全膝关节置换术中使用氨甲环酸的临床疗效[J]. 中华关节外科杂志(电子版), 2014,6(8): 718-722.

[13] Irwin A,Khan SK, Jameson SS,et al.Oral versus intravenous tranexamic acid in enhanced-recovery primary total hip and knee replancement:results of 3000 procedures. Bone Joint J. 2013;95B(11):1556-1561.

[14] 付德杰,陈凯宁,杨柳,等.氨甲环酸对全膝关节置换术失血量影响的系统评价[J].中国矫形外科杂志, 2012,13(20): 1172-1177.

[15] 刘江俊,刘忠强,田少奇,等.氨甲环酸对减少单侧全膝关节置换术后出血的疗效观察[J]. 中国矫形外科杂志, 2014, 23(22):2144-2148.

[16] Yang ZG, Chen WP,Wu LD.Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty; a mate-analysis. J Bone Surg Am. 2012; 13;1153-1159.

[17] Alshryda S, Sarda P,Sukeik M,et al.Tranexamic acid in total knee replacement:a systemmatic review and mate-analysis. J Bone Joint Surg Br. 2011;12:1577-1585.

[18] 席少华,周朝波,赵桂林,等.氨甲环酸在全膝关节置换术中局部应用和静脉应用的止血效果比较[J]. 实用药物与临床, 2015, 18(4): 205-206.

[19] 侯振扬,苏长征,庞涛,等.初次单次骨水泥型全膝关节置换:氨甲环酸使用方式对失血量的影响[J].中国组织工程研究, 2015, 19(9):1329-1334.

[20] 崔晓红,巫洪波.静脉滴注联合关节内灌注氨甲环酸对膝关节置换患者失血的护理影响[J].北方药学,2015,12(1): 195-196.

[21] Hegde C, Wasnik S, Kulkami S, et al. Simultaneous bilateral computer assisted total arthroplasty: the effect of intravenous or intraarticular acid. J Arhtroplasty. 2013;28(100):1888-1891.

[22] 王立强,张卫星,刘建刚,等.不同引流方式对全膝关节置换术后患者的影响[J].临床合理用药杂志,2015,8(4): 157-158.

[23] 汪锡龙,尚希福,贺瑞,等. 关节内注射氨甲环酸联合引流管夹闭3小时方案减少初次单膝关节置换术患者围手术期失血的有效性及安全性研究[J].中国全科医学,2015, 18(6):657-664.

[24] 郑萍,翁绳健,吴立忠,等. 关节腔内注射氨甲环酸对单侧人工膝关节置换术后引流量的影响[J].中国骨与关节损伤杂志, 2015,30(4):357-359.

[25] 杨朝君,孙智文,张爱民,等. 氨甲环酸关节腔注射联合引流管夹闭3小时在单侧全膝关节置换术中止血效果分析[J].中华损伤与修复杂志(电子版),2014,9(6):640-645.

[26] 蒋华,颜宇,马红兵,等.静脉与关节腔内使用氨甲环酸对全膝关节置换术失血量的影响比较[J].中国药业,2015, 24(12):44-46.

[27] Alshryda S,Mason J,Vaghela M,et al.Topic (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement:a randomized controlled trail(TRANX-K). J Bone Joint Surg. 2013;95(21):1961-1968.

[28] 岳辰,谢锦伟,蔡东风,等.静脉联合局部应用氨甲环酸减少初次全髋关节置换术围手术期失血的有效性及安全性研究[J].中华骨与关节外科杂志,2015,8(1):44-48.

[29] 王健,杨伟胤,王可良,等.脊柱手术静脉应用氨甲环酸减少出血的荟萃分析[J].实用医学杂志,2015,31(2):279-282.

[30] Moniar RN, Kumaer G, Singhi T, et al. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res. 2012;470(9): 2605-2612.

[31] Good L,Peterson E, Lisander B. Tranexamic acid decreases extermal blood loss but not hidden blood loss in total knee replacement. Br J Anaesth.2003; 90(5):596-599.

[32] 王登文,孙志国.随机双盲安慰剂对照研究全膝关节置换术中使用氨甲环酸的有效性和安全性[J].中国矫形外科杂志,2014,22 (12):1063-1067.

[33] 陈晓涛,谢守宁,王凯, 等.人工全膝关节置换术中使用氨甲环酸的疗效研究[J].中国修复重建外科杂志.2014, 28(11): 1338- 1341.

[34] 李林涛,吴海山,袁帅,等.全膝关节置换术应用不同剂量氨甲环酸有效性的研究[J].解放军医药杂志,2015,27(4): 32-36.

[35] 韩文峰,张珑,张攀,等.局部和静脉应用氨甲环酸减少初次全膝关节置换术后失血量对比研究[J].国际骨科学杂志, 2014,35(4): 269-271.

[36] 计忠伟,包倪荣,赵建宁,等.关节腔注射氨甲环酸对全膝关节置换术后疗效影响的Mate分析[J].中国骨与关节损伤杂志, 2015,30(2):164-168.

[37] Yang Y,Lv YM,Ding PJ,et al.The reduction of blood loss with intra-articular injection of tranexamic acid in unilateral total knee arthroplasty without operative drains: a randomized controlled trail. Eur J Orthop Surg Traumatol. 2014.

[38] 汪锡龙,尚希福,贺瑞,等.多模式止血方案对减少单膝关节置换术围手术期失血的有效性[J].临床骨科杂志, 2015, 18(1):35-38.

[39] 侯振扬,苏长征,庞涛,等.初次单侧骨水泥型全膝关节置换:氨甲环酸使用方式对失血量的影响[J].中国组织工程研究, 2015,19(9):1329-1334.

[40] 刘江俊,姚永远,赵鑫,等.不同剂量氨甲环酸对单膝关节置换术后失血量的影响[J].青岛大学医学院学报, 2015, 51(2):163-168.

[41] 罗犇,庄颜峰.氨甲环酸在全膝关节置换术中作用的研究进展[J].实用医学杂志,2015,31(4):668-670.

[42] 谢锦伟,岳辰,裴福兴.氨甲环酸在全髋关节置换术中的有效性与安全性研究进展[J].中国矫形外科杂志, 2014, 22(20):1856-1860.

[43] Zhang XL. Tranexamic Acid [M]//State Food and Drug Administration Center for Drug Evalution. Clinical Drug Reference. Chengdu: Sichuan Science and Technology Press, 2008:828-829.

[44] US Food and Drug Administration.Lysteda (tranexamic acid) label information [EB/OL]?. FDA, 2012 [2013-3-3]. Availablefrom:http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022430s002lbl.pdf.Accessed.

[45] Andersson L, Eriksson O, Hedlund PO, et al. Special considerations with regard to dosage of tranexamic acid in patients with chronic renal diseases. Urol Res. 1978;6(2): 83-88.

[46] Charoencholvanich K,Sinwttanasakul P,Narkbunnam R,et al.Temporary champing of drain combined with tranexamic acid reduce blood loss after total knee arthroplasty; a prospective randomized controlled train.BMC Musculoskelet Disord. 2012;13:124.

[47] 张瑜哲,金毅,苏礼,等.氨甲环酸减少初次单侧全膝关节置换术后失血量的临床研究[J].中国矫形外科杂志,2013, 21(8):762-765.

[48] Park KH,Lcc SR,Jin JM,et al.The Efficacy and Safety of Postoperative Autologous Transfusion of Filtered Shed Blood and Anti-coagulant Prophylaxis in total Knee Arthroplasty Patients.Knee Surg Relat Res. 2012;24(1):14-18.

[49] 武其文,胡丽华.人类输血技术发展的历史回顾及思考[J].医学与哲学:临床决策论坛版,2008,29(7):77-80.

[50] Amin A,Watson A,Mangwani J,et al.A prospective randomised controlled trial of autologous retransfusion in total knee replacement.J Bone Joint Surg Br. 2008; 90(4):451-454.